Phibro Animal Health

PAHC

Market cap $2.39B

Phibro Animal Health rides on strong Animal Health and vaccine demand, but macro risks and generics pressure cloud its outlook despite standout stock gains.

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck right now?

Phibro Animal Health, Deluxe, Remitly Global and BrightSpring Health Services, Inc. (BTSG) represent four compelling small-cap stocks.

PAHC stock surges 152% in a year, fueled by strong animal health demand, Zoetis MFA integration and growing vaccine momentum.

How investors can find the best "Strong Buy" momentum stocks to add to their portfolios heading into April and throughout 2026.

The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. TPR, PAHC, ADSK and AMP are some such stocks.

Phibro Animal Health surges 126.9% in a year as MFA integration and vaccine demand drive growth, but Mecadox regulatory risks and macro pressures loom.

EAT, PAHC and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 12th, 2026.

CEO Jack Bendheim sold 14,080 shares indirectly through BFI Co. LLC over multiple dates for proceeds of ~$728,000 at an average price around $51.68 per share. The transaction represented 20.83% of Mr.

CROX joins three other low-PEG stocks screening for growth, liquidity and value metrics to help investors sidestep potential traps.